2010
  1. Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, Sakamoto M, Komatsu H, Ueda R, Wada M, Furukawa TA.（in press）Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: prevalence, associated factors, and impact on quality of life: Cancer Science.
  2. Hashimoto N, Nakaaki S, Omori IM, Fujioi J, Noguchi Y, Murata Y, Sato J, Tatsumi H, Torii K, Mimura M, and FurukawaTA. (in press) Distinct neuropsychological profiles of three ma jor symptom dimensions in obsessive-compulsive disorder. Psychiatry Reserch
  3. Ando M, Morita T, Akechi T & Hirai K (in press). Development of a Japanese Benefit Finding Scale (JBFS) for cancer patients. Am J Hospice Palliat Med.
  4. Watanabe N, Furukawa TA, Shimodera S, Morokuma I, Katsuki F, Fujita H, Sasaki M, Kawamura C & Perlis ML (in press) Brief behavioral therapy for refractory insomnia in residual depression: Assessor-blind, randomized controlled trial. Journal of Clinical Psychiatry.
  5. Akechi T, Okuyama T, Sagawa R, Uchida M, Nakaguchi T, Ito Y & Furukawa TA (in press) Social anxiety disorder as a hidden psychiatric commorbidity among cancer patients. Palliative and Supportive Care.
  6. Kinoshita Y, Kingdon D, Kinoshita K, Kinoshita Y, Saka K, Arisue Y, Dayson D, Nakaaki S, Fukuda K, Yoshida K, Harris S & Furukawa TA (in press) Fear of negative evaluation is associated with delusional ideation in non-clinical population and patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology.
  7. Asai, M., Akizuki, N., Akechi, T., Nakano, T., Shimizu, K., Umezawa, S., Ogawa, A., Matsui, Y. & Uchitomi, Y. (in press). Psychiatric disorders and stress factors experienced by staff members in cancer hospitals: a preliminary finding from psychiatric consultation service at National Cancer Center Hospitals in Japan. Palliative and Supportive Care.
  8. Ando, M, Morita, T & Akechi, T (in press). Factors in the Short-Term Life Review that affect spiritual well-being in patients. Journal of Hospice and Palliative Nursing.
  9. Ando, M, Morita, T, Akechi, T & Ifuku, Y (in press). A qualitative study of mindfulness-based meditation therapy in Japanese cancer patients. Support Care Cancer.
  10. Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, Akazawa T, Yamashita H, Toyama T & Furukawa TA (in press) Patient's perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology.
  11. Ogawa S, Furukawa TA, Nakano Y, Funayama T, Watanabe N, Noguchi Y & Sasaki M (in press) Interoceptive hypersensitivity as prognostic factor among patients with panic disorder who have received cognitive behavioral therapy. Journal of Beahvior Therapy and Experimental Psychiatry.
  12. Kojima M, Hayano J, Suzuki S, Seno H, Kasuga H, Takahashi H, Toriyama T, Kawahara H & Furukawa TA (in press) Depression, alexythymia and long-term mortality in chronic hemodialysis patients. Psychotherapy and Psychosomatics.
  13. Wang XS, Cleeland C, Mendoza TR, Yun HO, Wang Y, Okuyama T, Johnson V, (in press) Impact of Cultural and Linguistic Factors on Symptom Reporting by Patients with Cancer. Journal of the National Cancer Institute.
  14. Katsumata R, Sagawa R, Akechi T, Shinagawa Y, Nakaaki S, Inagaki A, Okuyama T, Akazawa T & Furukawa TA (in press) A case with Hodgkin lymphoma and fronto-temporal degeneration (FTLD)-like dementia facilitated by chemotherapy. Japanese Journal of Clinical Oncology.
  15. Ando, M, Morita, T, Akechi, T & Okamoto, T (in press). Efficacy of short-term life review interviews on the spiritual well-being of terminally ill cancer patients. Journal of Pain and Symptom Management.
  16. Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (in press) Safety reporting and adverse event profile of mirtazapine described in randomised controlled trials in comparison with other classes of antidepressants in the acute phase treatment for depression: Systematic review. CNS Drugs.
  17. Chen J, Furukawa TA, Nakano Y, Ietsugu T, Ogawa S, Funayama T, Watanabe N, Noda Y & Rapee RM (in press) Video feedback with peer ratings in naturalistic anxiety-provoking situations for social anxiety disorder: preliminary report. Journal of Behavior Therapy and Experimental Psychiatry.
  18. Martin-Sanchez E, Furukawa TA, Taylor J & Martin JL (in press) Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine.
  19. Azuma H, Katsumata R, Ichikawa U, Akechi T & Furukawa TA (in press) Paroxysmal nonkinesigenic dyskinesia with depression treated by bilateral electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences.
  20. Furukawa TA (in press) Assessment of mood: Guides for clinicians. Journal of Psychosomatic Research.
  21. Akechi T, Okamura H, Nakano T, Akizuki N, Okamura M, Shimizu K, Okuyama T, Furukawa T.A & Uchitomi Y (in press). Gender differences in factors associated with suicidal ideation in major depression among cancer patients. Psychooncology.
  22. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa T, Tokudome S & Ishiguro N (in press) Depression, inflammation and pain in rheumatoid arthritis patients. Arthritis Care and Research.
  23. Kingdon D, Vincent S, Vincent S, Kinoshita Y& Turkington D (in press) Destigmatising schizophrenia: does changing terminology reduce negative attitudes? Psychiatric Bulletin.
  24. Saito M, Iwata N, Kawakami N, Matsuyama Y, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T & Kikkawa T (in prress) Evaluation of the DSM-IV and ICD-10 criteria for depresssive disorders in a community population in Japan using item response theory. International Journal of Methods in Psychiatric Research.
  25. Nakaaki S, Murata Y, Sato J, Shinagawa Y, Hongo J, Tatsumi H, Hirono N, Mimura M & Furukawa TA (in press) Impact of depression on insight into memory capacity in patients with Alzheimer disease. Alzheimer Disease and Associated Disorders.
  26. Nakaaki S, Murata Y, Sato J, Shinagawa Y, Hongo J, Tatsumi H, Hirono N, Mimura M & Furukawa TA (in press) Association between apathy/depression and executive function in patients with Alzheimer disease. International Psychogeriatrics.
  27. Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, Shimada A, Akechi T, Miyashita M & Adachi I (in press) Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Annals of Oncology.
  28. Kojima M, Kojima T, Ishiguro N, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Furukawa TA, Suzuki S & Tokudome S (in press) Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis. Journal of Psychosomatic Research.
  29. Furukawa TA, Watanabe N & Omori IM (in press) What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD. In Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V. (eds Goldberg D, Kendler KS, Sirovatka P & Regier DA). Arlington, VA: American Psychiatric Association.
  30. Fujimori M, Akechi T, Akizuki N, Okamura M, Oba A, Sakano Y & Uchitomi Y (in press) Good communication when receiving bad news about cancer in Japan. Psycho-Oncology.
  31. Azuma H, Negi A, Hattori M, Akechi T & Furukawa TA (in press) Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine: a case report. Epilepsia.
  32. Akechi T, Ishiguro C, Okuyama T, Endo C, Sagawa R, Uchida M & Furukawa TA (in press) Delirium training program for nurses. Psychosomatics.
  33. Akazawa T, Akechi T, Morita T, Miyashita M, Sato K, Tsuneto S, Shima Y & Furukawa TA (in press) Self-perceived burden in terminally ill cancer patients: A categorization of care strategies based on bereaved family members' perspective. Journal of Pain and Symptom Management.
  34. Yamamoto N, Inada T, Shimodera S, Morokuma I & Furukawa TA (in press) Brief PANSS (bPANSS) to assess and monitor the overall severity of schizophrenia. Psychiatry and Clinical Neurosciences.
  35. Katsumata R, Sagawa R, Akechi T, Shinagawa Y, Nakaaki S, Inagaki A, Okuyama T, Akazawa T & Furukawa TA (in press) A case with Hodgkin lymphoma and fronto-temporal degeneration (FTLD)-like dementia facilitated by chemotherapy. Japanese Journal of Clinical Oncology.
  36. Ando, M, Morita, T, Akechi, T & Okamoto, T (in press). Efficacy of short-term life review interviews on the spiritual well-being of terminally ill cancer patients. Journal of Pain and Symptom Management.
  37. Chen J, Furukawa TA, Nakano Y, Ietsugu T, Ogawa S, Funayama T, Watanabe N, Noda Y & Rapee RM (in press) Video feedback with peer ratings in naturalistic anxiety-provoking situations for social anxiety disorder: preliminary report. Journal of Behavior Therapy and Experimental Psychiatry.
  38. Martin-Sanchez E, Furukawa TA, Taylor J & Martin JL (in press) Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine.
  39. Azuma H, Katsumata R, Ichikawa U, Akechi T & Furukawa TA (in press) Paroxysmal nonkinesigenic dyskinesia with depression treated by bilateral electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences.
  40. Furukawa TA (in press) Assessment of mood: Guides for clinicians. Journal of Psychosomatic Research.
  41. Akechi T, Okamura H, Nakano T, Akizuki N, Okamura M, Shimizu K, Okuyama T, Furukawa T.A & Uchitomi Y (in press). Gender differences in factors associated with suicidal ideation in major depression among cancer patients. Psychooncology.
  42. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa T, Tokudome S & Ishiguro N (in press) Depression, inflammation and pain in rheumatoid arthritis patients. Arthritis Care and Research.
  43. Kingdon D, Vincent S, Vincent S, Kinoshita Y& Turkington D (in press) Destigmatising schizophrenia: does changing terminology reduce negative attitudes? Psychiatric Bulletin.
  44. Saito M, Iwata N, Kawakami N, Matsuyama Y, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T & Kikkawa T (in prress) Evaluation of the DSM-IV and ICD-10 criteria for depresssive disorders in a community population in Japan using item response theory. International Journal of Methods in Psychiatric Research.
  45. Nakaaki S, Murata Y, Sato J, Shinagawa Y, Hongo J, Tatsumi H, Hirono N, Mimura M & Furukawa TA (in press) Impact of depression on insight into memory capacity in patients with Alzheimer disease. Alzheimer Disease and Associated Disorders.
  46. Nakaaki S, Murata Y, Sato J, Shinagawa Y, Hongo J, Tatsumi H, Hirono N, Mimura M & Furukawa TA (in press) Association between apathy/depression and executive function in patients with Alzheimer disease. International Psychogeriatrics.
  47. Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, Shimada A, Akechi T, Miyashita M & Adachi I (in press) Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Annals of Oncology.
  48. Kojima M, Kojima T, Ishiguro N, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Furukawa TA, Suzuki S & Tokudome S (in press) Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis. Journal of Psychosomatic Research.
  49. Furukawa TA, Watanabe N & Omori IM (in press) What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD. In Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V. (eds Goldberg D, Kendler KS, Sirovatka P & Regier DA). Arlington, VA: American Psychiatric Association.
  50. Fujimori M, Akechi T, Akizuki N, Okamura M, Oba A, Sakano Y & Uchitomi Y (in press) Good communication when receiving bad news about cancer in Japan. Psycho-Oncology.
  51. Azuma H, Negi A, Hattori M, Akechi T & Furukawa TA (in press) Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine: a case report. Epilepsia.
  52. Kessler RC, Colpe LJ, Gruber M, Furukawa TA & Zaslavsky AM (in press) Screening for serious mental illness in the general population with the K6 screening scale: Results from the WHO World Mental Health (WMH) Survey Initiative. International Journal of Methods in Psychiatric Research.
  53. Kojima M, Kojima T, Ishiguro N & Furukawa TA (2010) Exploring the link between depression and rheumatoid arthritis: prospects for optimal therapeutic success. International Journal of Clinical Rheumatology, 5, 273-275.
  54. Kessler RC, Green JG, Gruber MJ, Sampson NA, Bromet E, Cuitan M, Furukawa TA, Gureje O, Hinkov H, Hu CY, Lara C, Lee S, Mneimneh Z, Myer L, Oakley-Browne M, Posada-Villa J, Sagar R, Viana MC & Zaslavsky AM (2010) Screening for serious mental illness in the general populationj with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. International Journal of Methods in Psychiatric Research, 19, 4-22.
  55. Yamamoto N, Inada T, Shimodera S, Morokuma I & Furukawa TA (2010) Brief PANSS (bPANSS) to assess and monitor the overall severity of schizophrenia. Psychiatry and Clinical Neurosciences, 64, 262-267.
  56. Akechi T, Ishiguro C, Okuyama T, Endo C, Sagawa R, Uchida M & Furukawa TA (2010) Delirium training program for nurses. Psychosomatics, 51, 106-111.
  57. Furukawa TA, Watanabe N & Omori IM (2010) What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD. In Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V. (eds Goldberg D, Kendler KS, Sirovatka P & Regier DA), pp. 71-104. Arlington, VA: American Psychiatric Association.
  58. Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2010) Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs, 24, 35-53.

PAGETOP